Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Am J Kidney Dis. 2016 Dec 4;69(3):389–399. doi: 10.1053/j.ajkd.2016.08.041

Table 4.

Mean Pre-Dialysis Blood Pressure and Serum Concentrations of Cardiac Troponin T and N-terminal-proBNP, by Treatment Group

Placebo
(N = 26)
600 mg Coenzyme
Q10 (N = 18)
1200 mg Coenzyme
Q10 (N = 21)

Troponin T, ng/ml
  Baseline 0.05 (0.04, 0.07) 0.11 (0.07, 0.15) 0.09 (0.04, 0.14)
  1 month 0.08 (0.04, 0.11) 0.11 (0.07, 0.16) 0.08 (0.03, 0.13)
  2 months 0.05 (0.04, 0.08) 0.10 (0.07, 0.14) 0.08 (0.02, 0.15)
  4 months 0.07 (0.04, 0.10) 0.11 (0.07, 0.15) 0.06 (0.02, 0.10)
  p-valuea Reference 0.71 0.10
N-terminal-proBNP, pg/ml
  Baseline 8412 (2672, 13,151) 8862 (4262, 13,461) 6794 (2668, 10,920)
  1 month 11,294 (5033, 17,555) 8857 (2958, 14,757) 7768 (2443, 13,094)
  2 months 10,740 (5579, 15,901) 11,169 (4714, 17.624) 6062 (0, 12,353)
  4 months 9562 (2803, 16,321) 13,510 (5752, 21,268) 2601 (0, 5558)
  p-valuea Reference 0.92 0.09
Pre-dialysis systolic blood pressure, mmHg
  Baseline 133 (126, 140) 144 (134, 155) 138 (131, 146)
  1 month 136 (127, 145) 144 (136, 152) 143 (131, 154)
  2 months 141 (130, 151) 146 (135, 157) 143 (131, 154)
  4 months 138 (127, 150) 140 (131, 150) 128 (112, 143)
  p-valuea Reference 0.87 0.90
Pre-dialysis diastolic blood pressure, mmHg
  Baseline 73 (67, 79) 78 (68, 89) 75 (69, 81)
  1 month 73 (66, 79) 78 (72, 84) 77 (68, 85)
  2 months 77 (69, 85) 79 (70, 87) 77 (69, 85)
  4 months 75 (68, 82) 77 (71, 84) 70 (62 (78)
  p-valuea Reference 0.99 0.93

Note: Results reported are from the primary intention-to-treat analysis. Values are least squares means (95% confidence interval), adjusted for age, sex, race, and etiology of ESRD.

a

p-value for comparison of average treatment effect from generalized estimating equation model, adjusted for age, sex, race, etiology of ESRD, and baseline measurements; reference group: placebo. Outcome measurements log transformed prior to analysis.